NCT00682695 Genetic and Environmental Risk Factors for Hemorrhagic Stroke Status RECRUITING Phase N/A
NCT00664846 Standard Medical Management in Secondary Prevention of Ischemic Stroke in China Status COMPLETED Phase NA
NCT00663416 REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients Status TERMINATED Phase PHASE2
NCT00657969 Looking For Genetic and Environmental Risk Factors and Therapeutic Aspects in Cervical Artery Dissections Status UNKNOWN Phase N/A
NCT00651729 Safety Study of Botulinum Toxin Type A for the Treatment of Focal Upper Limb Poststroke Spasticity Status COMPLETED Phase PHASE2
NCT00651690 Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment Status COMPLETED Phase PHASE2
NCT00647998 The Darbepoetin Alfa for Ischemic Surgical Complications (DISC) Dose Finding Trial Status COMPLETED Phase PHASE2
NCT00643864 Mirror-Box Training in Adults With Chronic Hemiparesis Secondary to Stroke Status TERMINATED Phase NA
NCT00640367 Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke Status COMPLETED Phase PHASE3
NCT00638248 Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) Status COMPLETED Phase PHASE1/PHASE2
NCT00637468 EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Status TERMINATED Phase PHASE3